Xtant Medical Holdings (XTNT) Cash & Current Investments (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Cash & Current Investments for 16 consecutive years, with $17.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Current Investments rose 178.54% year-over-year to $17.3 million; the TTM figure through Dec 2025 stood at $17.3 million (up 178.54% YoY), while the FY2025 annual figure was $17.3 million, up 178.54% from the prior year.
• Cash & Current Investments improved to $17.3 million in Q4 2025 per XTNT's latest filing, from $10.6 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $20.5 million in Q2 2021 and bottomed at $4.4 million in Q2 2023.
• Historically, Cash & Current Investments has averaged $11.8 million across 5 years, with a median of $9.7 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Current Investments soared 685.43% — and 2023, when it plunged 73.6%.
• Xtant Medical Holdings' Cash & Current Investments stood at $18.4 million in 2021, then increased by 11.53% to $20.5 million in 2022, then sank by 71.12% to $5.9 million in 2023, then increased by 5.03% to $6.2 million in 2024, then surged by 178.54% to $17.3 million in 2025.
• Business Quant data shows XTNT's Cash & Current Investments at $17.3 million in Q4 2025, $10.6 million in Q3 2025, and $7.0 million in Q2 2025.